SCHEMBL6636091

SCHEMBL6636091

Cn1c(SCc2ccc(C(=N)N)cc2)nc2cc(NS(=O)(=O)c3cccc4cccnc34)ccc21

nearest known ligand 0.77

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
F2 P00734 14/20 0.77
ALDH1A1 P00352 2/20 0.47
PKM P14618 1/20 0.46
ST14 Q9Y5Y6 1/20 0.45
BRD4 O60885 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635570 0.87 F2 (0.79) F2ALDH1A1PKMST14BRD4
SCHEMBL6638878 0.86 F2 (0.78) F2ALDH1A1PKMST14BRD4
SCHEMBL6636395 0.86 F2 (0.58) F2ALDH1A1PKMBRD4MEN1
Hydrochloric Acid SCHEMBL8032926 0.86 F2 (0.98) F2ALDH1A1PKMST14BRD4
Hydrochloric Acid SCHEMBL7984494 0.84 F2 (0.80) F2
Hydrochloric Acid SCHEMBL8031754 0.84 F2 (0.75) F2ALDH1A1PKMST14BRD4
Hydrochloric Acid SCHEMBL8026588 0.82 F2 (0.74) F2ALDH1A1ST14MEN1KMT2A
Hydrochloric Acid SCHEMBL6634654 0.82 F2 (0.69) F2ALDH1A1ST14BRD4MEN1
SCHEMBL6636298 0.80 F2 (0.79) F2ALDH1A1
SCHEMBL6637241 0.80 F2 (0.68) F2ALDH1A1ST14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed